Subscribe To
Pharmaceuticals stocks, etfs could have power beyond 2022
Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus v...
February 4, 2022, 11:09 am
Pharmaceuticals stocks, etfs could have power beyond 2022
Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus v...
February 4, 2022, 11:09 am
Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward
Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccin...
February 4, 2022, 8:54 am
Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward
Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccin...
February 4, 2022, 8:54 am
Valneva - pfizer choose three-dose schedule for lyme vaccine candidate moving forward
Valneva SE VALN and Pfizer Inc PFE have reported further Phase 2 data for their Lyme disease vaccin...
February 4, 2022, 8:54 am
Novavax can still succeed, but it's facing high risks
Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change ...
February 3, 2022, 8:34 am
Novavax can still succeed, but it's facing high risks
Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change ...
February 3, 2022, 8:34 am
Novavax can still succeed, but it's facing high risks
Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change ...
February 3, 2022, 8:34 am
U.k. authorizes novavax's covid-19 shot
Shares of Novavax Inc. NVAX, -6.03% gained 0.9% in premarket trading on Thursday after the company said its COVID-19 v...
February 3, 2022, 8:33 am
U.k. authorizes novavax's covid-19 shot
Shares of Novavax Inc. NVAX, -6.03% gained 0.9% in premarket trading on Thursday after the company said its COVID-19 v...
February 3, 2022, 8:33 am
U.k. authorizes novavax's covid-19 shot
Shares of Novavax Inc. NVAX, -6.03% gained 0.9% in premarket trading on Thursday after the company said its COVID-19 v...
February 3, 2022, 8:33 am
Novavax files for u.s. authorization. is the stock finally a buy?
Covid-19 vaccine developer Novavax's stock indicated on Monday that it had finally officially filed for...
February 3, 2022, 7:30 am
Novavax files for u.s. authorization. is the stock finally a buy?
Covid-19 vaccine developer Novavax's stock indicated on Monday that it had finally officially filed for...
February 3, 2022, 7:30 am
Novavax files for u.s. authorization. is the stock finally a buy?
Covid-19 vaccine developer Novavax's stock indicated on Monday that it had finally officially filed for...
February 3, 2022, 7:30 am
Why biden has eased up on facebook over covid misinformation
When U.S. President Joe Biden accused Facebook of "killing people" by spreading vaccine lies in July, m...
February 3, 2022, 6:14 am
Why biden has eased up on facebook over covid misinformation
When U.S. President Joe Biden accused Facebook of "killing people" by spreading vaccine lies in July, m...
February 3, 2022, 6:14 am
Why biden has eased up on facebook over covid misinformation
When U.S. President Joe Biden accused Facebook of "killing people" by spreading vaccine lies in July, m...
February 3, 2022, 6:14 am
Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand
McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...
February 3, 2022, 5:50 am
Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand
McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...
February 3, 2022, 5:50 am
Mckesson q3 earnings beat street view, raises fy22 outlook boosted by covid-19 vaccine demand
McKesson Corp MCK reported third-quarter FY22 adjusted EPS of $6.15, +34% Y/Y, and easily beating the analyst consensus of $5.42. Thousands of new t...
February 3, 2022, 5:50 am